Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Connect with industry professionals using effective methods. Discover ways to enhance your network and open new opportunities.
16,127 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Applied Materials is set to report Q2 results after the close, as investors weigh demand signals for AI chips and adv...
Ripple’s institutional push continues, but XRP remains range-bound. This report breaks down the moves, flows, and wha...
Bit Digital faces shifting crypto markets. This guide breaks down what to watch in the Q1 2026 earnings transcript an...
A little-known Social Security lever lets claimants suspend benefits at full retirement age to earn an $432 monthly r...
The Bay Area’s luxury housing market tightens as AI-powered wealth concentrates in upscale ZIP codes. Meanwhile, more...
Nvidia has expanded its stake in CoreWeave and is pursuing a broader AI infrastructure strategy that goes beyond chip...
Bitcoin plunged to multi-week lows as traders priced in renewed tensions between the U.S. and Iran, triggering massiv...
DES delivers monthly payouts tied to a cash-dividend weighted small-cap index. The income looks reliable, but a conce...
On-chain tokenized real-world assets approach $30 billion, but DeFi liquidity trails far behind, underscoring uneven ...
WaterBridge stock since IPO has surged about 55% as institutional investors push deeper into water management for ene...
An activist investor is pressing for board seats in a high-stakes proxy battle at Lululemon, highlighting questions a...